MedPath

A Clinical trial to study the effect of the drug Perungaya Chooranam in patients having Diabetes Mellitus (Madhumegam)

Phase 2
Recruiting
Conditions
MALE AND FEMALE WITH POLYURIA,POLYDYPSIA,BURNING SENSATION AND NUMBNESS OVER THE FOOT AND PALM
Registration Number
CTRI/2018/03/012505
Lead Sponsor
Government Siddha Medical College
Brief Summary

This is a single Non randomised open clinical trial to study the safety and efficacy of Siddha trial drug Perungaya chooranam. The trial drug is given 2grams twice a day for 90 days. Clinical trial is conducted after conducting Pre clinical toxicity study. The trial drug Perungaya chooranam is mentioned in Sarabenthira vaithiya rathnavali. During the trial all the study related data will be recorded and documented. After the completion of trial all the data will be analysed statistically.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Newly identified type II cases only Subject within 30-60 years Blood glucose(F)- 120-140mg/dl Blood glucose(PP)-180-280mg/dl Blood glucose(R)-200-300mg/dl HbA1C.
  • 6.5 TO 8% Polyuria Polyphagia Polydypsia Nocturia Fatigue.
Exclusion Criteria

H/O Insulin Dependent Diabetes Mellitus H/O Cardiovascular Disease H/O Diabetic Nephropathy H/O Diabetic Retinopathy Pregnant Women, Lactating mothers,T.B affected individuals.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome is mainly assessed by reduced blood sugar and HbA1C Level and reduced in clinical symptoms90 Days
Secondary Outcome Measures
NameTimeMethod
Secondary outcome is assessed by comparing the safety parameters before and after treatment90 DAYS

Trial Locations

Locations (1)

Aringar Anna Government Hospital of Indian Medicine

🇮🇳

Chennai, TAMIL NADU, India

Aringar Anna Government Hospital of Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Dr Nithya K
Principal investigator
9176808837
nithyb4u@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.